Market Insights: Targeted Therapies to Deliver Improved Patient Outcomes in Oncology

Webcast Recorded on June 27, 2023.

Supported through funding by Seagen.

This non-promotional, sponsored webinar reviewed health plan best practice recommendations for targeted therapies in oncology with an impressive panel of oncology and managed care experts.

As the US Market continues to evolve, so does the complexity of payers and providers navigating best practices that ensure their members have access to high-quality, cost-effective medications. AMCP’s Market Insights Best Practice provides recommendations from our managed care members to help their peers make the best coverage and access decisions.

Oncology is seeing accelerated development of new expression-based therapy classes with the potential to deliver unprecedented improvements in patient outcomes. One class of particular interest are antibody-drug conjugates (ADCs). ADCs are amongst the fastest growing drug classes in oncology, as they combine the best features of monoclonal anti-bodies and small molecule drugs, creating a single moiety that is highly specific and cytotoxic. Managed care and payer professionals play a central role in improving value in and access to cancer care.

In this webinar, a panel of experts discussed health plan best practices related to target therapies in oncology. Following the presentation, the panelists held a live Q&A session.

Learn About:

At the completion of this activity, participants should be able to:

• Discuss key insights into the benefits of antibody drug conjugates and site of care administration
• Describe practices for the evidence evaluation of antibody drug conjugates and strategies to improve transparency of coverage policies
• Explore health plan practices which support the safe use of antibody drug conjugates
• Examine strategies available to managed care professionals to guide treatment sequencing of antibody drug conjugates
• Identify components of high-quality care that improve health equity and address unmet needs in cancer care

Expert Faculty:

• Jim Kenney, RPh, MBA (Moderator)
  Founder and President
  JTKenney, LLC
• Laura Bobolts, PharmD, BCOP
  SVP, Clinical Strategy and Growth
  OncoHealth
• Christopher Fausel, PharmD, MHA, BCOP
  Clinical Manager
  Oncology Pharmacy, Indiana University Health
• Jorge Garcia, PharmD, MS, MHA, MBA, FACHE
  Assistant Vice President – System Oncology Pharmacy
  Baptist Health South Florida
• Kirollos S. Hanna, PharmD, BCPS, BCOP, FACCC
  Director of Pharmacy
  Minnesota Oncology
• Ryan Haumschild, PharmD, MS, MBA
  Director of Pharmacy Services
  Emory Healthcare and Winship Cancer Institute
• Dana McCormick, RPh, FAMCP
  Director of Pharmacy
  Blue Cross Blue Shield of Texas
• Tim Mok, PharmD, BCPS, BCOP
  Hematology Oncology Pharmacy Research Analyst
  Kaiser Permanente